Benjamin Derman, MD
| Board Certified American Board of Internal Medicine Medical Oncology, American Board of Internal Medicine Hematology, American Board of Internal Medicine |
| Director of Multiple Myeloma Clinic and Tumor Board University of Chicago, Chicago, IL |
| Assistant Professor Hematology/Oncology, University of Chicago, Chicago, IL |
Ben Derman, MD, is an assistant professor of medicine at the University of Chicago. He specializes in multiple myeloma and other plasma cell disorders. He is interested in integrating measurable residual disease (MRD) diagnostics and immunotherapeutic strategies at the bedside.
His research endeavors are focused on MRD in myeloma: novel ways to assess for residual disease, how to use MRD to guide clinical decision making, and how MRD may be used to identify possible cures. Additionally, he is actively engaged in researching novel CAR T-cell therapies and other immunotherapies for patients with myeloma.
American Physician
